Vismodegib in Treating Patients With Basal Cell Carcinoma (BCC)

Clinical trial NCT01631331 · COMPLETED

Trial details

NCT number: NCT01631331
Sponsor: Stanford University
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Basal Cell Carcinoma of the Skin Recurrent Skin Cancer

Start date: 2012-06-01
Primary completion: 2015-09-17
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.